A descriptive and prognostic study of systemic sclerosis-associated myopathies

Annals of the Rheumatic Diseases

Volumn 68, Issue 9, 2009, Pages 1474-1477

  Ranque, B ^a   Authier, F J ^b   Le Guern, V ^a   Pagnoux, C ^a   Berezne, A ^a   Allanore, Y ^a   Launay, D ^c   Hachulla, E ^c   Kahan, A ^a   Cabane, J ^d   Gherardi, R ^b   Guillevin, L ^a   Mouthon, L ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c UNIV LILLE   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; MUSCLE BIOPSY; MYOPATHY; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

EID: 69949166111     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.095919     Document Type: Article

References (15)

1. Clements PJ. Systemic sclerosis (scleroderma) and related disorders: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 2000;14:1-16. (Pubitemid 30353021)
2. Tamby MC, Chanseaud Y, Guillevin L, Mouthon L. New insights into the pathogenesis of systemic sclerosis. Autoimmun Rev 2003;2:152-157 (Pubitemid 37443852)
3. Medsger TA Jr, Rodnan GP, Moossy J, Vester JW. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1968;11:554-568
4. Thompson JM, Bluestone REGLB, Dorling J, Johnson M. Skeletal muscle involvement in systemic sclerosis. Ann Rheum Dis 1969;28:281-288
5. Clements PJ, Furst DE, Campion DS, Bohan A, Harris R, Levy J, et al. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 1978;21:62-71.
6. Hausmanowa-Petrusewicz I, Jablonska S, Blaszczyk M, Matz B. Electromyographic findings in various forms of progressive systemic sclerosis. Arthritis Rheum 1982;25:61-65 (Pubitemid 12215970)
7. Ranque B, Authier FJ, Berezne A, Guillevin L, Mouthon L. Systemic sclerosisassociated myopathy. Ann N Y Acad Sci 2007;1108:268-282
8. Ringel RA, Brick JE, Brick JF, Gutmann L, Riggs JE. Muscle involvement in the scleroderma syndromes. Arch Intern Med 1990;150:2550-2552
9. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46:428-440
10. Masi AT. Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 1988;15:894-898
11. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-1576 (Pubitemid 32660630)
12. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337-345
13. Olsen NJ, King LE Jr, Park JH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am 1996;22:783-796
14. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.
15. Evans DJ, Cashman SJ, Walport M. Progressive systemic sclerosis: autoimmune arteriopathy. Lancet 1987;1:480-482 (Pubitemid 17036516)